In today’s Pharmaceutical Executive Daily, Cognito Therapeutics and Nexcure secure new financing rounds to advance their pipelines, artificial intelligence and large language models reshape ...

Q4 2025 Earnings Call March 5, 2026 4:30 PM ESTCompany ParticipantsAllan Kells - Vice President of Investor RelationsSean Duffy ...

A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.

Because Omada Health supports weight health with or without GLP-1s, and helps members manage diabetes, hypertension, and now cholesterol, we have also seen strong growth among members not on GLP-1s.

In keeping with its recently accelerated release cadence, OpenAI has shipped GPT-5.4 (including GPT-5.4 Thinking and GPT-5.4 Pro). This update comes at a critical time, as recent events have led some ...

GoodRx reports 2026 will see higher health insurance premiums, Medicare changes, and many opting out of coverage due to ...